All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Best Low-Cost GLP-1 Telehealth Companies By Safety Profile

This page is built for price-sensitive users who are still trying to avoid the thinnest and riskiest-looking telehealth options. The goal is not to celebrate the cheapest offer at any cost, but to sort the lower-cost field by visible safety profile and operational credibility.

Quick Answer

The best low-cost GLP-1 telehealth options in this dataset are the companies that combine affordability with cleaner visible public signals and less opacity, not just the lowest sticker price.

Methodology

We prioritize visible public-record cleanliness, support-model clarity, and how much operational structure sits behind the price point. Lower cost helps a company qualify for this page, but not if it comes with materially worse transparency or regulatory context.

Ranked Companies And Facilities

Rank #1

Henry Meds

Telehealth Provider

Full profile

Telehealth company centered on compounded GLP-1 weight loss access through online consultations and subscription-style recurring billing.

Henry Meds ranks first in this low-cost group because it stays highly relevant on affordability without carrying the same explicit warning-letter burden as some of the thinner compounded-access competitors in this dataset.

Warning Letters

0

Recalls

0

FDA Registration

not shown

States Licensed

48

Henry Meds is usually compared against other lower-cost compounded GLP-1 telehealth providers rather than premium obesity-medicine programs.

Its appeal is convenience and price simplicity, but that makes source transparency and service quality more important, not less.

Patients should verify how the company handles pharmacy disclosure, cancellations, dose changes, and support when treatment problems arise.

Rank #2

Found

Telehealth Provider

Full profile

Telehealth weight-loss platform combining GLP-1 access with coaching, nutrition support, and a broader behavior-change framework.

Found ranks highly because it gives price-sensitive users more program structure and support credibility than a pure low-friction access model, which improves the overall safety profile even if it is not the absolute cheapest option.

Warning Letters

0

Recalls

0

FDA Registration

not shown

States Licensed

50

Found combines medication access with coaching and habit-change support.

It is usually evaluated as a guided weight-loss platform, not just a telehealth prescription service.

Patients should verify how much support is included versus what is positioned as optional.

Rank #3

MEDVi

Telehealth Provider

Full profile

Bootstrapped GLP-1 telehealth platform focused on lower-cost compounded weight loss medication access, typically using asynchronous intake and a lean support model.

MEDVi remains a major low-cost name, but it ranks below the top spots because its warning-letter context materially weakens the safety story compared with cleaner low-cost alternatives.

Warning Letters

1

Recalls

0

FDA Registration

not shown

States Licensed

42

MEDVi is positioned as a lower-cost, high-volume telehealth option rather than a high-touch obesity medicine program.

The company relies on partner pharmacies rather than presenting itself here as a directly FDA-registered drug establishment.

Its FDA warning-letter history makes marketing language and compounded-drug disclosures especially important for patients to review.

Rank #4

ivim Health

Telehealth Provider

Full profile

Telehealth platform offering GLP-1 weight-loss treatment with remote consultations, recurring follow-up, and at-home lab components.

ivim Health ranks well because it offers a lower-friction path than premium programs without looking as thin or support-light as the weakest price-led sellers.

Warning Letters

0

Recalls

0

FDA Registration

not shown

States Licensed

45

ivim positions itself between low-touch prescribing and premium structured programming.

Its recurring-consultation model should be evaluated for substance, not just presentation.

Patients should confirm pharmacy source, lab expectations, and how side effects are escalated.

Rank #5

LifeMD

Telehealth Provider

Full profile

Publicly traded telehealth company (NASDAQ: LFMD) offering GLP-1 weight management through a broader portfolio of direct-to-consumer health brands.

LifeMD remains competitive in this group because its scale and public-company structure provide stronger operating credibility than many lower-cost GLP-1 brands, even if cost is not its only differentiator.

Warning Letters

0

Recalls

0

FDA Registration

not shown

States Licensed

50

LifeMD is a larger public telehealth platform, not a niche GLP-1-only operator.

Its weight-loss offering should be assessed on actual program mechanics, not corporate scale alone.

Patients should verify medication source, support structure, and brand-versus-program specifics.

Rank #6

Alpha Medical

Telehealth Provider

Full profile

Multi-service telehealth platform offering GLP-1 prescribing for weight management alongside women's health, dermatology, mental health, and primary care.

Alpha Medical rounds out this list because it still offers a more unified branded telehealth experience than the thinnest low-cost funnels, even if it does not project the same support or specialization as the brands above it.

Warning Letters

0

Recalls

0

FDA Registration

not shown

States Licensed

48

Alpha Medical is a multi-condition telehealth brand rather than a dedicated GLP-1 clinic.

Its value proposition is convenience across multiple care categories, not just weight-loss specialization.

Patients should ask which pharmacy relationship applies and what ongoing obesity-care support is actually included.

What This Ranking Suggests

Henry Meds stays relevant here because affordability matters, but users still need to press hard on source transparency and support quality.

Found and ivim Health can rank well when users want lower-friction access without dropping all the way down to the thinnest models.

MEDVi remains important in low-cost search, but its warning-letter context keeps it from reading as the cleanest visible safety profile in this price-sensitive group.

Bottom Line

In this dataset, the strongest low-cost options are not always the very cheapest. They are the brands that combine affordability with cleaner visible public signals and less operational opacity.

Related Comparisons

Side-by-side pages that deepen the decision paths behind this ranking.

View comparison hub

Frequently Asked Questions

Why is the cheapest company not automatically ranked first?

Because this page ranks low-cost options by visible safety profile, not by price alone. The cheapest offer can still carry worse transparency or warning-letter risk.

Does low cost always mean compounded GLP-1 access?

Not always, but low-cost GLP-1 search often overlaps with compounded-access workflows, which makes disclosure and support quality especially important.

Sources Used In This Guide

FormBlends company safety profiles

Primary internal profile set used to compare low-cost telehealth operators on visible safety profile and operational credibility.

Open source

FormBlends comparison hub

Used to compare lower-cost telehealth names side by side before assigning rank order.

Open source